IRIS
SORMANI, MARIA PIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 48.061
AS - Asia 4.476
NA - Nord America 2.006
SA - Sud America 412
AF - Africa 86
OC - Oceania 9
Continente sconosciuto - Info sul continente non disponibili 1
Totale 55.051
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 47.251
SG - Singapore 2.104
US - Stati Uniti d'America 1.913
CN - Cina 1.132
VN - Vietnam 699
FR - Francia 409
BR - Brasile 265
HK - Hong Kong 167
DE - Germania 102
FI - Finlandia 70
MX - Messico 64
AR - Argentina 61
IN - India 43
BD - Bangladesh 41
GB - Regno Unito 41
IQ - Iraq 41
JP - Giappone 39
CH - Svizzera 32
ZA - Sudafrica 26
NL - Olanda 25
RU - Federazione Russa 25
SA - Arabia Saudita 21
PK - Pakistan 19
EC - Ecuador 18
TH - Thailandia 18
VE - Venezuela 17
CL - Cile 16
ID - Indonesia 16
TR - Turchia 15
CO - Colombia 14
ES - Italia 14
PH - Filippine 13
DZ - Algeria 12
KE - Kenya 12
UA - Ucraina 12
KR - Corea 11
TN - Tunisia 10
CA - Canada 9
IE - Irlanda 9
MA - Marocco 9
NP - Nepal 9
AU - Australia 8
AZ - Azerbaigian 8
JO - Giordania 8
PE - Perù 8
AL - Albania 7
AT - Austria 7
MY - Malesia 7
TW - Taiwan 7
UZ - Uzbekistan 7
EG - Egitto 6
KZ - Kazakistan 6
SE - Svezia 6
AE - Emirati Arabi Uniti 5
CZ - Repubblica Ceca 5
QA - Qatar 5
RS - Serbia 5
SY - Repubblica araba siriana 5
UY - Uruguay 5
BO - Bolivia 4
DO - Repubblica Dominicana 4
GR - Grecia 4
IL - Israele 4
IR - Iran 4
KH - Cambogia 4
PL - Polonia 4
RO - Romania 4
BA - Bosnia-Erzegovina 3
BG - Bulgaria 3
BH - Bahrain 3
BY - Bielorussia 3
CR - Costa Rica 3
OM - Oman 3
PT - Portogallo 3
SI - Slovenia 3
EE - Estonia 2
GT - Guatemala 2
HN - Honduras 2
HU - Ungheria 2
KG - Kirghizistan 2
LB - Libano 2
MM - Myanmar 2
PA - Panama 2
PY - Paraguay 2
SK - Slovacchia (Repubblica Slovacca) 2
TT - Trinidad e Tobago 2
AM - Armenia 1
AO - Angola 1
BE - Belgio 1
BW - Botswana 1
CM - Camerun 1
CU - Cuba 1
CV - Capo Verde 1
CY - Cipro 1
DK - Danimarca 1
ET - Etiopia 1
GF - Guiana Francese 1
GM - Gambi 1
HR - Croazia 1
JM - Giamaica 1
Totale 55.031
Salva come PNG Salva come JPEG
Città #
Genova 30.364
Genoa 10.410
Rapallo 3.390
Vado Ligure 2.824
San Jose 957
Singapore 950
Lauterbourg 387
Ashburn 272
Ho Chi Minh City 196
Hong Kong 157
Hanoi 149
Beijing 129
Bordighera 104
New York 102
Council Bluffs 96
Frankfurt am Main 70
Helsinki 68
Santa Clara 64
Mexico City 37
Da Nang 36
Haiphong 35
Tokyo 31
Zurich 30
Tianjin 29
São Paulo 24
Los Angeles 20
Baghdad 16
Can Tho 15
Guangzhou 15
Hải Dương 15
Johannesburg 14
Milan 14
Chicago 13
Rome 12
Shanghai 12
Amsterdam 11
Cardiff 11
Nairobi 11
Orem 11
Des Moines 10
Nuremberg 10
Phoenix 10
Schiffdorf 10
St Louis 10
Bangkok 9
Riyadh 9
Santiago 9
Amman 8
Atlanta 8
Baku 8
Rio de Janeiro 8
Biên Hòa 7
Dublin 7
Ninh Bình 7
Tashkent 7
Vĩnh Long 7
Brasília 6
Buffalo 6
Carapicuíba 6
Dhaka 6
Guayaquil 6
Naples 6
Thái Nguyên 6
Tirana 6
Turin 6
Bogotá 5
Bologna 5
Brooklyn 5
Changsha 5
Chennai 5
Curitiba 5
Doha 5
Istanbul 5
Jeddah 5
Medford 5
Quito 5
Thái Bình 5
Acalanes Ridge 4
Belo Horizonte 4
Buenos Aires 4
Bắc Ninh 4
Cairo 4
Caracas 4
Chongqing 4
City of London 4
Concepción 4
Dallas 4
Denver 4
Erbil 4
Houston 4
Itaquaquecetuba 4
Karachi 4
Kyiv 4
Lahore 4
London 4
Madrid 4
Medellín 4
Montevideo 4
Moscow 4
Phnom Penh 4
Totale 51.451
Salva come PNG Salva come JPEG
Nome #
High-throughput screening for modulators of ACVR1 transcription: discovery of potential therapeutics for fibrodysplasia ossificans progressiva. 286
Finger motor performance as a new quantitative clinical endpoint in multiple sclerosis 238
Breast cancer incidence after hormonal treatments for infertility: systematic review and meta-analysis of population-based studies 226
Clinical epidemiology of ALS in Liguria, Italy. 213
A parametric model fitting time to first event for overdispersed data: application to time to relapse in multiple sclerosis. 212
Ultrasound versus magnetic resonance imaging for Morton neuroma: systematic review and meta-analysis 203
Evaluation of insulin resistance in a cohort of HIV-infected youth. 199
Adjunct screening with tomosynthesis or ultrasound in women with mammography-negative dense breasts: Interim report of a prospective comparative trial 199
Different MRI patterns in MS worsening after stopping fingolimod 199
Clinical epidemiology of amyotrophic lateral sclerosis in Liguria, Italy: An update of LIGALS register 198
Autologous haematopoietic stem cell transplantation with an intermediate intensity conditioning regimen in multiple sclerosis: the Italian multi-centre experience. 194
Urinary JCV-DNA Testing during Natalizumab Treatment May Increase Accuracy of PML Risk Stratification. 193
Breast Density Assessment Using a 3T MRI System: Comparison among Different Sequences 191
Assessing long-term prognosis improvement as a consequence of treatment pattern changes in MS. 189
Use of maraviroc in clinical practice: a multicenter observational study 186
The long-term effect of AHSCT on MRI measures of MS evolution: a five-year follow-up study. 186
Modelling the distribution of cortical lesions in multiple sclerosis. 185
Indirect comparisons of treatment effects in multiple sclerosis. 185
Can we measure long-term treatment effects in multiple sclerosis? 184
Early onset may predict G101W CDKN2A founder mutation carrier status in Ligurian melanoma patients. 184
Benefits of glucocorticoids in non-ambulant boys/men with Duchenne muscular dystrophy: A multicentric longitudinal study using the Performance of Upper Limb test 182
A prospective comparative trial of adjunct screening with tomosynthesis or ultrasound in women with mammography-negative dense breasts (ASTOUND-2) 182
Defining the clinical course of multiple sclerosis: the 2013 revisions. 181
The daily diary and the questionnaire are not equivalent for the evaluation of bowel habits. 180
Remote ischemic postconditioning as a strategy to reduce acute kidney injury during primary PCI: A post-hoc analysis of a randomized trial. 179
Quantitative assessment of finger motor performance: Normative data 179
Intense immunosuppression followed by autologous haematopoietic stem cell transplantation as a therapeutic strategy in aggressive forms of multiple sclerosis 178
6 minute walk test in Duchenne MD patients with different mutations: 12 month changes. 178
Extending the Interval of Natalizumab Dosing: Is Efficacy Preserved? 177
Risk factors for chronic kidney disease among human immunodeficiency virus-infected patients: A European case control study. 176
Effect of radiotherapy and chemotherapy on the risk of mucositis during intensity-modulated radiation therapy for oropharyngeal cancer. 174
99mTc-white cell scanning to detect gut inflammation in children with inflammatory bowel diseases or spondyloarthropathies 173
Assessment of disease activity in acromegaly by means of a single blood sample: comparison of the 120th minute postglucose value with spontaneous GH secretion and with the IGF system 173
Intense immunosuppression followed by autologous stem cell transplantation in severe multiple sclerosis. 173
A T-cell epitope encoded by a subset of HLA-DPB1 alleles determines nonpermissive mismatches for hematologic stem cell transplantation. 172
Pharmacokinetics of Lopinavir Determined with an ELISA Test in Youths with Perinatally Acquired HIV. 172
Subclinical motor impairment assessed with an engineered glove correlates with magnetic resonance imaging tissue damage in radiologically isolated syndrome 172
Identification of multiple sclerosis patients at highest risk of cognitive impairment using an integrated brain magnetic resonance imaging assessment approach 171
Intra-observer, inter-observer and inter-scanner variations in brain MRI volume measurements in multiple sclerosis 170
BCR-ABL nuclear entrapment kills human CML cells: ex-vivo study on 35 patients with the combination of Imatynib Mesylate and Leptomycin B 170
Functional changes in Duchenne muscular dystrophy: a 12-month longitudinal cohort study. 170
Laparoscopic splenectomy for hematologic diseases: a preliminary analysis performed on the Italian Registry of Laparoscopic Surgery of the Spleen (IRLSS). 170
Effects of hepatitis C virus infection on the pharmacokinetics of ritonavir-boosted atazanavir in HIV-1-infected patients. 170
Low intensity lympho-ablative regimen followed by autologous hematopoietic stem cell transplantation in severe forms of multiple sclerosis: A MRI-based clinical study. 169
Bimonthly assessment of magnetization transfer magnetic resonance imaging parameters in multiple sclerosis: a 14-month, multicentre, follow-up study. 168
Autologous hematopoietic stem cell transplantation in multiple sclerosis: A phase II trial. 167
Ethics of placebo-controlled clinical trials in multiple sclerosis: a reassessment 166
Optimizing therapy early in multiple sclerosis: An evidence-based view 166
Treatment decisions in multiple sclerosis - insights from real-world observational studies. 166
A phase I/II study of altered fractionated IMRT alone for intermediate T-stage oropharyngeal carcinoma. 166
Single-Port Versus Conventional Laparoscopic Cholecystectomy: Better Cosmesis at the Price of an Increased Incisional Hernia Rate? 166
Modeling the distribution of new MRI cortical lesions in multiple sclerosis longitudinal studies. 165
Bone marrow transplantation from unrelated donors: the impact of mismatches with substitutions at position 116 of the human leukocyte antigen class I heavy chain 164
Bone quality in perinatally HIV-infected children: role of age, sex, growth, HIV infection, and antiretroviral therapy 164
Abnormal connectivity of the sensorimotor network in patients with MS: a multicenter fMRI study. 163
Body mass index in Th1 and Th2 diseases. 163
Innovative quantitative testing of hand function in Charcot-Marie-Tooth neuropathy 163
Changes in the normal-appearing brain tissue and cognitive impairment in multiple sclerosis 162
Magnetization transfer imaging to monitor the evolution of MS: a 1-year follow-up study 162
Evidence-based guidelines: MAGNIMS consensus guidelines on the use of MRI in multiple sclerosis - Clinical implementation in the diagnostic process 162
Arginase 2 is expressed by human lung cancer, but it neither induces immune suppression, nor affects disease progression 162
The influence of slice orientation on brain MRI lesion load measurement in multiple sclerosis 161
Statistical issues related to the use of MRI data in multiple sclerosis 161
The most frequently asked question to a statistician: The sample size 161
Age-related changes in Conventional, Magnetization Transfer, and Diffusion-Tensor MR Imaging Findings: Study with Whole-Brain Tissue Histogram Analysis. 160
Sexual behaviour in Ligurian (Northern Italy) adolescents and young people: suggestions for HPV vaccination policies 160
Laryngeal long-term morbidity after supraglottic laryngectomy and postoperative radiation therapy 159
Improving the characterization of radiologically isolated syndrome suggestive of multiple sclerosis. 158
Evidence-based guidelines: MAGNIMS consensus guidelines on the use of MRI in multiple sclerosis - Establishing disease prognosis and monitoring patients 158
Assessing association of comorbidities with treatment choice and persistence in MS: A real-life multicenter study 158
Six minute walk test in type III spinal muscular atrophy: a 12month longitudinal study. 157
Magnetic resonance imaging as a potential surrogate for relapses in multiple sclerosis: a meta-analytic approach 156
A diagnostic score for molecular analysis of hereditary autoinflammatory syndromes with periodic fever in children 156
Serum p55 and p75 tumour necrosis factor receptors as markers of disease activity in juvenile chronic arthritis 156
Clinical baseline factors predict response to natalizumab: their usefulness in patient selection. 155
Long-term impact of interferon or Glatiramer acetate in multiple sclerosis: A systematic review and meta-analysis 155
Approved drugs for multiple sclerosis: The challenge of choice 155
Dosimetric predictors of diarrhea during radiotherapy for prostate cancer. 155
Treatment of multiple sclerosis with rituximab: A multicentric Italian-Swiss experience 155
MRI measures should be a primary outcome endpoint in Phase III randomized, controlled trials in multiple sclerosis: yes. 154
Sensitivity and reproducibility of volume change measurements of different brain portions on magnetic resonance imaging in patients with multiple sclerosis. 154
The distribution of the magnetic resonance imaging response to glatiramer acetate in multiple sclerosis 154
Time to first relapse as an endpoint in multiple sclerosis clinical trials. 154
Long-term Outcomes After Autologous Hematopoietic Stem Cell Transplantation for Multiple Sclerosis 154
Autologous hematopoietic stem cell transplantation in multiple sclerosis: A meta-analysis 154
Clinical activity after fingolimod cessation: Disease reactivation or rebound? 154
A conventional and magnetization transfer MRI study of the cervical cord in patients with multiple sclerosis 153
Thirteen years of follow-up in patients with adjustable silicone gastric banding for obesity: weight loss and constant rate of late specific complications. 153
A prospective, randomized, controlled trial of autologous haematopoietic stem cell transplantation for aggressive multiple sclerosis: a position paper. 153
Scoring treatment response in patients with relapsing multiple sclerosis. 153
A brain magnetization transfer MRI study with a clinical follow up of about four years in patients with clinically isolated syndromes suggestive of multiple sclerosis. 153
External validation of unsupervised COVID-19 clinical phenotypes and their prognostic impact 152
Short-term evolution of individual enhancing MS lesions studied with magnetization transfer imaging 152
A diffusion tensor MRI study of patients with MCI and AD with a 2-year clinical follow-up 152
A Comprehensive Review on Copemyl(®) 152
Autologous haematopoietic stem cell transplantation for treatment of multiple sclerosis 151
Determinants of therapy switch in multiple sclerosis treatment-naïve patients: A real-life study 151
Statistical power of MRI monitored trials in multiple sclerosis: new data and comparison with previous results 150
Magnetization transfer MRI metrics predict the accumulation of disability 8 years later in patients with multiple sclerosis. 150
Axonal injury in early multiple sclerosis is irreversible and independent of the short-term disease evolution. 150
Totale 17.075
Salva come PNG Salva come JPEG
Categoria #
all - tutte 181.269
article - articoli 180.240
book - libri 0
conference - conferenze 1.029
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 362.538
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.105 0 0 0 0 0 0 0 0 0 482 301 322
2021/20225.124 139 294 581 477 146 361 317 1.214 236 422 299 638
2022/20234.155 462 197 50 416 709 795 19 308 765 58 324 52
2023/20242.426 116 354 57 216 199 513 181 158 145 69 135 283
2024/20256.979 157 607 270 404 944 772 726 953 305 362 620 859
2025/202611.310 1.378 316 855 1.078 1.482 1.358 2.154 621 939 1.129 0 0
Totale 56.121